Inspira completes regulatory submission for INSPIRA ART100 in UAE

Inspira Technologies (IINN) announced that it has completed the regulatory submission of its FDA-cleared INSPIRA ART100 system to the United Arab Emirates Ministry of Health and Prevention. Final approval is expected within days, marking a decisive step toward commercial entry into the Gulf region. This regulatory milestone follows successful high-level government discussions in the UAE, during which Inspira laid the groundwork for potential nationwide deployment and clinical integration of the ART100 system following the approval by the MOHAP. The achievement further advances Inspira’s global commercialization roadmap.